Despite biotech’s outperformance year-to-date, the authors of today’s article still see the industry as attractive – and they outline three key strategic themes driving their investment thesis for biotech (and especially biopharma, which they note is the fastest growing part of the industry). One of those themes? Demand growth arising from the response to COVID-19. For more, CLICK HERE.